4.2 Article

A novel mitochondrial DNA m.7507A>G mutation is only pathogenic at high levels of heteroplasmy

期刊

NEUROMUSCULAR DISORDERS
卷 25, 期 3, 页码 262-267

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2014.11.002

关键词

Mitochondrial tRNA; Threshold effect; Heteroplasmy; OXPHOS; Hearing loss

资金

  1. Wellcome Trust [096919Z/11/Z]
  2. UK NHS Highly Specialised Rare Mitochondrial Disorders of Adults and Children Service
  3. MRC [MR/K000608/1] Funding Source: UKRI
  4. Medical Research Council [MR/K000608/1] Funding Source: researchfish

向作者/读者索取更多资源

We present a Dutch family with a novel disease-causing mutation in the mitochondrial tRNA(Ser(UCN)) gene, m.7507A>G. The index patient died during the neonatal period due to cardio respiratory failure and fatal lactic acidosis. A second patient, his cousin, has severe hearing loss necessitating cochlear implants and progressive exercise intolerance. Laboratory investigations of both patients revealed combined deficiencies of the enzyme complexes of the mitochondrial respiratory chain in several tissues. Reduced levels of fully assembled complexes I and IV in fibroblasts by BN-PAGE associated with (near) homoplasmic levels of the m.7507A>G mutation in several tissues and a severe reduction in the steady-state level of mt-tRNA(Ser(UCN)) in fibroblasts were observed. The novel mitochondrial DNA mutation was shown to segregate with disease; several healthy maternal family members showed high heteroplasmy levels (up to 76 +/- 4% in blood and 68 +/- 4% in fibroblasts) which did not lead to any alterations in the activities of the enzyme complexes of the respiratory chain in fibroblasts or clinical signs and symptoms. We hereby conclude that the m.7507A>G mutation causes a heterogeneous clinical phenotype and is only pathogenic at very high levels of mtDNA heteroplasmy. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据